Data / Drug companies / Fluphenazine hydrochloride
Fluphenazine hydrochloride: 29 companies and 107 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Fluphenazine hydrochloride is listed in the FDA National Drug Code Directory by 29 companies, with 107 products in commercial distribution. 107 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; injection, solution, and the newest product started marketing on July 3, 2026.
The request: Get every company that lists fluphenazine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 29
- Products
- 107
- Generic (ANDA) products
- 107 (100.0%)
- Application numbers
- 19
- Routes
- Oral, Intramuscular
- Brand names
- Fluphenazine Hydrochoride
- openFDA record search
- api.fda.gov
Companies that list fluphenazine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Ajanta Pharma USA Inc. | 4 | tablet | Generic drugs (ANDA) | January 5, 2023 |
| Alembic Pharmaceuticals Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | July 25, 2024 |
| Alembic Pharmaceuticals Limited | 4 | tablet, film coated | Generic drugs (ANDA) | July 25, 2024 |
| Amneal Pharmaceuticals NY LLC | 4 | tablet, film coated | Generic drugs (ANDA) | July 11, 2020 |
| Ani Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | March 1, 2021 |
| Aurobindo Pharma Limited | 4 | tablet | Generic drugs (ANDA) | August 18, 2023 |
| AvPAK | 4 | tablet, film coated | Generic drugs (ANDA) | July 6, 2022 |
| Camber Pharmaceuticals, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | November 18, 2025 |
| Chartwell RX, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | January 1, 2022 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | February 15, 2021 |
| Glenmark Pharmaceuticals Inc., USA | 4 | tablet, film coated | Generic drugs (ANDA) | November 6, 2023 |
| Golden State Medical Supply, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | January 7, 2021 |
| Lannett Company, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | August 25, 1988 |
| Major Pharmaceuticals | 4 | tablet, film coated | Generic drugs (ANDA) | August 25, 1988 |
| Marlex Pharmaceuticals, Inc. | 4 | tablet | Generic drugs (ANDA) | June 1, 2021 |
| Novadoz Pharmaceuticals LLC | 4 | tablet, film coated | Generic drugs (ANDA) | September 11, 2023 |
| Proficient Rx LP | 4 | tablet, film coated | Generic drugs (ANDA) | August 1, 2022 |
| Rising Pharma Holdings, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | June 7, 2024 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | April 14, 2022 |
| Upsher-Smith Laboratories, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | August 1, 2022 |
| Upsher-Smith Laboratories, LLC | 4 | tablet, film coated | Generic drugs (ANDA) | November 22, 2022 |
| Zameer Pharmaceuticals LLC | 4 | tablet, film coated | Generic drugs (ANDA) | January 1, 2022 |
| Zydus Lifesciences Limited | 4 | tablet, film coated | Generic drugs (ANDA) | May 28, 2021 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | May 28, 2021 |
| Coupler LLC | 3 | tablet, film coated | Generic drugs (ANDA) | June 5, 2026 |
| Remedyrepack Inc. | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | July 3, 2026 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | November 9, 2023 |
| Pai Holdings, LLC DBA Pai Pharma | 2 | elixir; solution, concentrate | Generic drugs (ANDA) | September 1, 2010 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | December 28, 2010 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 87 | 81.3% |
| Tablet | 17 | 15.9% |
| Injection, solution | 1 | 0.9% |
| Elixir | 1 | 0.9% |
| Solution, concentrate | 1 | 0.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 107 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Phenothiazine | 107 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.